The weekly data for Axsome's lead drug Auvelity (which has been approved for Major Depression Disorder), has turned in a new weekly prescription high three weeks in row to 10,400, for the latest week ending. Data from IQVIA. Thank you for reading.
Saturday, August 31, 2024
Saturday, August 17, 2024
GOLD Closes at Historical High
It's not too often we get to witness an asset that has been around for centuries, closing at an all-time high over $2500 per ounce. Gold has become a storage of wealth as the US debt continues to increase, and has historically acted as a source of value, during economic uncertainty and inflation. A weekly chart of gold, thank you for reading.
If inclined to learn more about inflation and currency depreciation, this book below is a short read written in 1912 about excess currency printing in France 1790, and how it destroyed the nation. Fiat Money Inflation in France.
Monday, August 5, 2024
Axsome Second Quarter Financial Results
Axsome Therapeutics released impressive second quarter results this morning. The biggest positive was that ADVANCE 2 for Alzheimer's Agitation, is to be released second half of 2024.
- Auvelity for MDD sales totaled $65 million for the quarter
- A New Drug Application for AXS-07 has been submitted
- Alzheimer's Agitation phase 3, to be released 2nd half 2024
- ADHD phase 3 clinical trial results, 2nd half 2024
The stock had a wild day due to overall market volatility, recording a low of 72.21 early, but closed at 83.21 end of day, outperforming the broader market sell-off. Thank you for reading.
Subscribe to:
Posts (Atom)